PDVAC Agenda 2021: HIV mAbs Preferred Product Characteristics

Overview

WHO Product Development for Vaccines Advisory Committee (PDVAC) - Virtual Consultation: HIV mAbs Preferred Product Characteristics: 15 April 2021

CHAIR: David Kaslow

The goal of this virtual session is to facilitate PDVAC review of the draft HIV mAbs PPC document. The circulated draft has incorporated feedback from the stakeholder meeting but has not yet undergone public consultation. The intended outcome is to finalize the draft PPC for public comment.

A second goal is to highlight critical aspects that require further consideration to facilitate future research, policy and implementation discussions for development and use of HIV mAbs. Such aspects would be reported separately in a scientific journal.